The safety and efficacy of tirofiban on prevention of vascular reocclusion following mechanical thro

• 作 者: 戴征
• 机 构: Dept Neurol,Jinling Hosp,Med Sch,Nanjing Univ,
• 出 处: China Medical Abstracts(Internal Medicine)
• 发表日期: 2017年03期
• 关键词: Nanjing retrospective glycoprotein prevention cohort enrolled stenosis antagonis

Objective To evaluate the safety and efficacy of low-dose platelet glycoproteinⅡb/Ⅲa antagonist tirofiban on preventing reocclusion during mechanical thrombectomy(MT)for in situ thrombosis(IST).Methods It is a retrospective cohort study,and 112 patients treated with MT,from the Nanjing Prospective Stroke Registration,were enrolled from February 2014 to October 2014.

Objective To evaluate the safety and efficacy of low-dose platelet glycoprotein IIb / IIIa antagonist tirofiban on preventing reocclusion during mechanical thrombectomy (MT) for in situ thrombosis (IST). Methods It is a retrospective cohort study, and 112 patients treated with MT, from the Nanjing Prospective Stroke Registration, were enrolled from February 2014 to October 2014.